Common genetic variants in candidate genes and risk of familial lymphoid malignancies

British Journal of Haematology

Volumn 146, Issue 4, 2009, Pages 418-423

  Liang, Xueying ^a   Caporaso, Neil ^a   McMaster, Mary Lou ^a   Ng, David ^a   Landgren, Ola ^a   Yeager, Meredith ^a   Chanock, Stephen ^a   Goldin, Lynn R ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Association; Candidate genes; Chronic lymphocytic leukaemia; Familial; Lymphoid malignancies

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6;

ARTICLE; CANCER GENETICS; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CHRONIC LYMPHATIC LEUKEMIA; DNA REPAIR; FAMILIAL CANCER; GENETIC LINKAGE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; OXIDATIVE STRESS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SPOUSE; WALDENSTROEM MACROGLOBULINEMIA;

CASE-CONTROL STUDIES; CELL LINE, TUMOR; GENETIC VARIATION; GENOTYPE; HODGKIN DISEASE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LOGISTIC MODELS; LYMPHOPROLIFERATIVE DISORDERS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK; TNF-RELATED APOPTOSIS-INDUCING LIGAND; WALDENSTROM MACROGLOBULINEMIA;

EID: 67749097763     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2009.07790.x     Document Type: Article

References (42)

1. Alexander, D.D., Mink, P.J., Adami, H.O., Chang, E.T., Cole, P., Mandel, J.S. Trichopoulos, D. (2007) The non-Hodgkin lymphomas: a review of the epidemiologic literature. International Journal of Cancer, 120 (Suppl. 12 1 39. (Pubitemid 46732571)
2. Barrett, J.C., Fry, B., Maller, J. Daly, M.J. (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics, 21, 263 265.
3. Benjamini, Y. Hochberg, Y. (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society. Series B (methodological), 57, 289 300.
4. Benjamini, Y., Drai, D., Elmer, G., Kafkafi, N. Golani, I. (2001) Controlling the false discovery rate in behavior genetics research. Behavioural Brain Research, 125, 279 284.
5. Chng, W.J., Schop, R.F., Price-Troska, T., Ghobrial, I., Kay, N., Jelinek, D.F., Gertz, M.A., Dispenzieri, A., Lacy, M., Kyle, R.A., Greipp, P.R., Tschumper, R.C., Fonseca, R. Bergsagel, P.L. (2006) Gene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myeloma. Blood, 108, 2755 2763.
6. Cordano, P., Lake, A., Shield, L., Taylor, G.M., Alexander, F.E., Taylor, P.R., White, J. Jarrett, R.F. (2005) Effect of IL-6 promoter polymorphism on incidence and outcome in Hodgkin's lymphoma. British Journal of Haematology, 128, 493 495.
7. Cozen, W., Gill, P.S., Ingles, S.A., Masood, R., Martinez-Maza, O., Cockburn, M.G., Gauderman, W.J., Pike, M.C., Bernstein, L., Nathwani, B.N., Salam, M.T., Danley, K.L., Wang, W., Gage, J., Gundell-Miller, S. Mack, T.M. (2004) IL-6 levels and genotype are associated with risk of young adult Hodgkin lymphoma. Blood, 103, 3216 3221.
8. Di Bernardo, M.C., Crowther-Swanepoel, D., Broderick, P., Webb, E., Sellick, G., Wild, R., Sullivan, K., Vijayakrishnan, J., Wang, Y., Pittman, A.M., Sunter, N.J., Hall, A.G., Dyer, M.J., Matutes, E., Dearden, C., Mainou-Fowler, T., Jackson, G.H., Summerfield, G., Harris, R.J., Pettitt, A.R., Hillmen, P., Allsup, D.J., Bailey, J.R., Pratt, G., Pepper, C., Fegan, C., Allan, J.M., Catovsky, D. Houlston, R.S. (2008) A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia. Nature Genetics, 40, 1204 1210.
9. Dicker, F., Kater, A.P., Fukuda, T. Kipps, T.J. (2005) Fas-ligand (CD178) and TRAIL synergistically induce apoptosis of CD40-activated chronic lymphocytic leukemia B cells. Blood, 105, 3193 3198.
10. Goldin, L.R. Caporaso, N.E. (2007) Family studies in chronic lymphocytic leukaemia and other lymphoproliferative tumours. British Journal of Haematology, 139, 774 779.
11. Goldin, L.R. Landgren, O. (2009) Autoimmunity and lymphomagenesis. International Journal of Cancer, 124, 1497 1502.
12. Goldin, L.R., Ishibe, N., Sgambati, M., Marti, G.E., Fontaine, L., Lee, M.P., Kelley, J.M., Scherpbier, T., Buetow, K.H. Caporaso, N.E. (2003) A genome scan of 18 families with chronic lymphocytic leukaemia. British Journal of Haematology, 121, 866 873.
13. Goldin, L.R., Pfeiffer, R.M., Gridley, G., Gail, M.H., Li, X., Mellemkjaer, L., Olsen, J.H., Hemminki, K. Linet, M.S. (2004a) Familial aggregation of Hodgkin lymphoma and related tumors. Cancer, 100, 1902 1908.
14. Goldin, L.R., Pfeiffer, R.M., Li, X. Hemminki, K. (2004b) Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia: results from the Swedish Family-Cancer Database. Blood, 104, 1850 1854.
15. Goldin, L.R., Landgren, O., McMaster, M.L., Gridley, G., Hemminki, K., Li, X., Mellemkjaer, L., Olsen, J.H. Linet, M.S. (2005a) Familial aggregation and heterogeneity of non-Hodgkin lymphoma in population-based samples. Cancer Epidemiology, Biomarkers and Prevention, 14, 2402 2406. (Pubitemid 41437843)
16. Goldin, L.R., McMaster, M.L., Ter-Minassian, M., Saddlemire, S., Harmsen, B., Lalonde, G. Tucker, M.A. (2005b) A genome screen of families at high risk for Hodgkin lymphoma: evidence for a susceptibility gene on chromosome 4. Journal of Medical Genetics, 42, 595 601.
17. Goldin, L.R., Björkholm, M., Kristinsson, S.Y., Turesson, I. Landgren, O. (2009) Elevated risk of chronic lymphocytic leukemia (CLL) and other indolent non-Hodgkin lymphomas among relatives of patients with chronic lymphocytic leukemia. Haematologica, 94, 647 653.
18. Gutierrez, N.C., Ocio, E.M., de Las Rivas, J., Maiso, P., Delgado, M., Ferminan, E., Arcos, M.J., Sanchez, M.L., Hernandez, J.M. San Miguel, J.F. (2007) Gene expression profiling of B lymphocytes and plasma cells from Waldenstrom's macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals. Leukemia, 21, 541 549.
19. Houlston, R.S. Peto, J. (2003) The future of association studies of common cancers. Human Genetics, 112, 434 435.
20. Houlston, R.S. Peto, J. (2004) The search for low-penetrance cancer susceptibility alleles. Oncogene, 23, 6471 6476.
21. Ishibe, N., Sgambati, M.T., Fontaine, L., Goldin, L.R., Jain, N., Weissman, N., Marti, G.E. Caporaso, N.E. (2001) Clinical characteristics of familial B-CLL in the National Cancer Institute Familial Registry. Leukaemia & Lymphoma, 42, 99 108.
22. Kaufmann, S.H. Steensma, D.P. (2005) On the TRAIL of a new therapy for leukemia. Leukemia, 19, 2195 2202.
23. Kawakami, M., Kawakami, K., Kioi, M., Leland, P. Puri, R.K. (2005) Hodgkin lymphoma therapy with interleukin-4 receptor-directed cytotoxin in an infiltrating animal model. Blood, 105, 3707 3713.
24. Kristinsson, S.Y., Bjorkholm, M., Goldin, L.R., McMaster, M.L., Turesson, I. Landgren, O. (2008) Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom's macroglobulinemia patients: a population-based study in Sweden. Blood, 112, 3052 3056.
25. Lan, Q., Zheng, T., Rothman, N., Zhang, Y., Wang, S.S., Shen, M., Berndt, S.I., Zahm, S.H., Holford, T.R., Leaderer, B., Yeager, M., Welch, R., Boyle, P., Zhang, B., Zou, K., Zhu, Y. Chanock, S. (2006) Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma. Blood, 107, 4101 4108.
26. Landgren, O., Linet, M.S., McMaster, M.L., Gridley, G., Hemminki, K. Goldin, L.R. (2006) Familial characteristics of autoimmune and hematologic disorders in 8,406 multiple myeloma patients: a population-based case-control study. International Journal of Cancer, 118, 3095 3098.
27. McMaster, M.L. Caporaso, N. (2007) Waldenstrom macroglobulinaemia and IgM monoclonal gammopathy of undetermined significance: emerging understanding of a potential precursor condition. British Journal of Haematology, 139, 663 671.
28. McMaster, M.L., Goldin, L.R., Bai, Y., Ter-Minassian, M., Boehringer, S., Giambarresi, T.R., Vasquez, L.G. Tucker, M.A. (2006) Genomewide linkage screen for Waldenstrom macroglobulinemia susceptibility loci in high-risk families. American Journal of Human Genetics, 79, 695 701.
29. McMaster, M.L., Csako, G., Giambarresi, T.R., Vasquez, L., Berg, M., Saddlemire, S., Hulley, B. Tucker, M.A. (2007) Long-term evaluation of three multiple-case Waldenstrom macroglobulinemia families. Clinical Cancer Research, 13, 5063 5069.
30. Nagel, S., Scherr, M., Quentmeier, H., Kaufmann, M., Zaborski, M., Drexler, H.G. MacLeod, R.A. (2005) HLXB9 activates IL6 in Hodgkin lymphoma cell lines and is regulated by PI3K signalling involving E2F3. Leukemia, 19, 841 846.
31. Packer, B.R., Yeager, M., Burdett, L., Welch, R., Beerman, M., Qi, L., Sicotte, H., Staats, B., Acharya, M., Crenshaw, A., Eckert, A., Puri, V., Gerhard, D.S. Chanock, S.J. (2006) SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes. Nucleic Acids Research, 34, D617 D621.
32. Purdue, M.P., Lan, Q., Kricker, A., Grulich, A.E., Vajdic, C.M., Turner, J., Whitby, D., Chanock, S., Rothman, N. Armstrong, B.K. (2007) Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study. Carcinogenesis, 28, 704 712.
33. Rothman, N., Skibola, C.F., Wang, S.S., Morgan, G., Lan, Q., Smith, M.T., Spinelli, J.J., Willett, E., De Sanjose, S., Cocco, P., Berndt, S.I., Brennan, P., Brooks-Wilson, A., Wacholder, S., Becker, N., Hartge, P., Zheng, T., Roman, E., Holly, E.A., Boffetta, P., Armstrong, B., Cozen, W., Linet, M., Bosch, F.X., Ennas, M.G., Holford, T.R., Gallagher, R.P., Rollinson, S., Bracci, P.M., Cerhan, J.R., Whitby, D., Moore, P.S., Leaderer, B., Lai, A., Spink, C., Davis, S., Bosch, R., Scarpa, A., Zhang, Y., Severson, R.K., Yeager, M., Chanock, S. Nieters, A. (2006) Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. The Lancet Oncology, 7, 27 38.
34. Scholz, M. Cinatl, J. (2005) Fas/FasL interaction: a novel immune therapy approach with immobilized biologicals. Medicinal Research Reviews, 25, 331 342.
35. Sellick, G.S., Webb, E.L., Allinson, R., Matutes, E., Dyer, M.J., Jonsson, V., Langerak, A.W., Mauro, F.R., Fuller, S., Wiley, J., Lyttelton, M., Callea, V., Yuille, M., Catovsky, D. Houlston, R.S. (2005) A high-density SNP genomewide linkage scan for chronic lymphocytic leukemia-susceptibility loci. American Journal of Human Genetics, 77, 420 429.
36. Sellick, G.S., Goldin, L.R., Wild, R.W., Slager, S.L., Ressenti, L., Strom, S.S., Dyer, M.J., Mauro, F.R., Marti, G.E., Fuller, S., Lyttelton, M., Kipps, T.J., Keating, M.J., Call, T.G., Catovsky, D., Caporaso, N. Houlston, R.S. (2007) A high-density SNP genome-wide linkage search of 206 families identifies susceptibility loci for chronic lymphocytic leukemia. Blood, 110, 3326 3333.
37. Skibola, C.F., Curry, J.D. Nieters, A. (2007) Genetic susceptibility to lymphoma. Haematologica, 92, 960 969.
38. Spink, C.F., Keen, L.J., Mensah, F.K., Law, G.R., Bidwell, J.L. Morgan, G.J. (2006) Association between non-Hodgkin lymphoma and haplotypes in the TNF region. British Journal of Haematology, 133, 293 300.
39. Storey, J.D. Tibshirani, R. (2003) Statistical significance for genomewide studies. Proceedings of the National Academy of Sciences of the United States of America, 100, 9440 9445.
40. Stylianou, E. Saklatvala, J. (1998) Interleukin-1. International Journal of Biochemistry and Cell Biology, 30, 1075 1079.
41. Vener, C., Guffanti, A., Pomati, M., Colombi, M., Alietti, A., La Targia, M.L., Bamonti-Catena, F. Baldini, L. (2000) Soluble cytokine levels correlate with the activity and clinical stage of Hodgkin's disease at diagnosis. Leukaemia & Lymphoma, 37, 333 339.
42. Wang, S.S., Cerhan, J.R., Hartge, P., Davis, S., Cozen, W., Severson, R.K., Chatterjee, N., Yeager, M., Chanock, S.J. Rothman, N. (2006) Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-hodgkin lymphoma. Cancer Research, 66, 9771 9780.